Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

http://www.wikidata.org/entity/Q36974939

about

The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug.Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders Involvement of 5-lipoxygenase in the corticosteroid-dependent amyloid beta formation: in vitro and in vivo evidence A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease.5-Lipoxygenase DNA methylation and mRNA content in the brain and heart of young and old mice.5-Lipoxygenase in mouse cerebellar Purkinje cells Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.Why pleiotropic interventions are needed for Alzheimer's disease.Benefits of neuropsychiatric phenomics: example of the 5-lipoxygenase-leptin-Alzheimer connection Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases.Suppression of oxidative stress and 5-lipoxygenase activation by edaravone improves depressive-like behavior after concussion.Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease.5-lipoxygenase as an endogenous modulator of amyloid β formation in vivo.Resolution of inflammation is altered in Alzheimer's disease Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model involvement of γ-secretase Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles.Regulation of gamma-secretase activating protein by the 5Lipoxygenase: in vitro and in vivo evidence Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice.Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus.Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer's disease mouse model 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease.Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study Gene Therapy Models of Alzheimer's Disease and Other Dementias.Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis The influence of 5-lipoxygenase on Alzheimer's disease-related tau pathology: in vivo and in vitro evidence.Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation 5-Lipoxygenase in the Prefrontal Cortex of Suicide Victims.5-Lipoxygenase and epigenetic DNA methylation in aging cultures of cerebellar granule cells Anticonvulsive Effects of Licofelone on Status Epilepticus Induced by Lithium-pilocarpine in Wistar Rats: a Role for Inducible Nitric Oxide Synthase.Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase.Novel lipid signaling pathways in Alzheimer's disease pathogenesis.5-Lipoxygenase inhibitors: a review of recent developments and patents.Immunohistochemical analysis of ubiquilin-1 in the human hippocampus: association with neurofibrillary tangle pathology.Lipid metabolism in Alzheimer's disease Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease.

P2860

Q26999358-4C270FB4-437E-46A6-90E0-229BA5A7D3C1 Q27322384-AA59F5A5-FC1E-4A31-BABE-77381DF1CE0A Q28278005-1172E579-2C24-45D2-B80F-EA9DBA11C2AA Q28476697-052D7B69-BA08-4F81-9766-0EC1426E089C Q28478380-21E15C70-D78D-4CA0-A4FD-94FBA380DC19 Q30540833-1BC4DB70-608D-4390-970C-7CA6BAB6ABDC Q33568502-BA7DFD89-4C7F-43B5-B359-E3CCEEA28569 Q33695445-DFCDF8FB-8FEC-4755-9942-2C641088E80C Q33832795-8AA0CA3C-7732-44CB-8906-1F59754A78B2 Q33876128-16BCDCFC-B7D7-4F4F-BE45-84BDA622509B Q34002860-77493D68-53C9-45D0-A125-6FB5FA90F09D Q34225004-29A2B054-86E5-413A-940B-5C389FF54907 Q34260323-B5E32348-11EC-45B1-B9F8-ECC417907165 Q34268115-1F5A956B-343A-4A4D-B0FE-63084B7D06E1 Q34551101-DA2F383D-A6A5-489A-B198-DA74A0E6DB6E Q34636148-B3A5E194-DAC6-47D5-9DCE-10F56BA7D30A Q34765889-18AA96A3-C7E6-4BD3-A7B8-DD8573D7D9A3 Q34805615-86C7B514-8849-4641-BA95-A6C899380E53 Q34948311-EB6FADA3-875D-458A-8CF1-B5833B162D54 Q35745694-2BC81E7F-F2D4-4EC3-8803-01B94B2F7595 Q35750756-DB67784E-F67E-47E1-81B4-72D3B835FA2A Q35844193-5A95022D-478C-425F-8778-BB9DD98304F7 Q35991969-EDAC6496-A705-409B-A69D-E02BC3806A79 Q36181709-8C6B517D-BDF0-4801-88A9-194939DEE033 Q36299503-4DC57025-D5FA-42E7-8B70-EB6261C1356E Q36316280-331C4044-ACB2-4DAB-8E95-4DA65C3E848D Q36524290-D8F0A5B7-2BF7-4083-B170-2166A652B0BC Q36777563-773A96C5-C2CB-4DD0-9EE5-777A2C8FA2DB Q37053817-EAA8E47B-FE3A-482B-9A37-BCF8E1FB975A Q37220361-5706A426-CAF3-49B7-9D77-CB9F9C5A2AD1 Q37409343-C7E81802-8013-4F6E-A58D-1725E232A579 Q37438444-44A67321-C407-45BA-92E6-78F892E1B66E Q37548964-18BF0557-FED5-4677-91E6-56961266E235 Q37627877-01625C87-9636-40CB-8117-4F0BE892F19B Q37678676-FA44668B-C566-4B49-914A-5C093A8D456B Q37697795-BFE819FD-F631-4AB1-9DAE-5D4E267B0C26 Q37724229-C8123107-036D-43DC-A149-46C9DE3FC20D Q38204719-20070D56-E4B6-4F1F-9BA1-607466CA20A3 Q38664541-E1F4F6F6-59A6-4ACF-B3BC-5349EFD491E3 Q38671719-F8D393DE-821D-4D3A-8B8B-393ABABB7ED1

P2860

Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

http://www.wikidata.org/entity/Q36974939

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Increased 5-lipoxygenase immun ...... ents with Alzheimer's disease.

@en

type

label

Increased 5-lipoxygenase immun ...... ents with Alzheimer's disease.

@en

prefLabel

Increased 5-lipoxygenase immun ...... ents with Alzheimer's disease.

@en

P1433

Q36974939-3FCC0A90-A59F-40C1-B8C9-F2B3B7EE0255

P1476

Q36974939-41C097CF-DAA9-4F4A-ADA5-12E5B06DBBA6

P2093

Q36974939-13427766-3896-4F52-AC8E-D05F94AAA5CE

Q36974939-15B1A7A3-EDE9-4C80-96BF-D3BB0F86A8A1

Q36974939-725DFF3D-2B07-4A6D-94A6-6A76612486A6

Q36974939-A41F30A7-7FFE-41E1-8A57-9ADAF73CBA4F

P2860

Q36974939-05E788B5-44A4-4FAF-BFC8-21A11BF8B8F7

Q36974939-0D77AC5B-2881-4BF5-A1C5-8C3C776ADD8B

Q36974939-10241837-57A4-4C2D-AFB8-CFF47831F527

Q36974939-169C4C1F-5759-40ED-9CC1-167296C676C9

Q36974939-1E6BB305-9681-4F32-B98D-09252E262970

Q36974939-1F4F174B-69E5-40CF-9ADF-EF26D2268566

Q36974939-27708698-E04B-43D2-B1B5-B6DCC1F97CDB

Q36974939-29752BED-6C26-4E0F-8599-912F73DF1A08

Q36974939-2C68C0A2-5D40-43D6-BB04-37857232C0BC

Q36974939-31DD6B41-A8B9-4AC6-8712-FD95CEC70401

P304

Q36974939-492EF688-943B-4355-A06C-D3B67EADE455

P31

Q36974939-E0887587-318B-47F5-9997-4794CF72DD1A

P356

Q36974939-71AD4069-AF41-4214-80FA-CB5B3F504AB1

P433

Q36974939-3BE4A0D2-F98E-4167-907E-BA5A9CDF0C3A

P478

Q36974939-292E30C5-0370-4507-A743-325DFEC11E9D

P50

Q36974939-AF079E6B-B2CA-4078-B041-C5C797AD797F

P577

Q36974939-478FF404-DAA4-48AF-B2E5-0A4CC65591D2

P5875

Q36974939-E3AF4D3E-D1EE-4E82-8811-44A9A9A0DCDF

P698

Q36974939-6EAC6916-885C-48B1-81E4-65B8F6AC019F

P921

Q36974939-8B725BB7-1759-4A02-91F2-AED8A864FE56

Q36974939-B8A62B16-9BDC-41A3-9C71-177CAB8A9EE7

P932

Q36974939-8468CB5B-94F3-4DC8-9B93-F7DC28B9477D

P356

JHC.2008.951855

P1433

Journal of Histochemistry & Cytochemistry

P1476

Increased 5-lipoxygenase immun ...... ients with Alzheimer's disease

@en

P2093

Eric E Abrahamson

http://www.w3.org/2001/XMLSchema#string

Hari Manev

http://www.w3.org/2001/XMLSchema#string

Milos D Ikonomovic

http://www.w3.org/2001/XMLSchema#string

Tolga Uz

http://www.w3.org/2001/XMLSchema#string

P2860

5-Lipoxygenase interacts with coactosin-like protein

12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress

Neuropathological stageing of Alzheimer-related changes

Inflammation and Alzheimer's disease

Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine

X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.

New anti-inflammatory treatment strategy in Alzheimer's disease.

Putative role of neuronal 5-lipoxygenase in an aging brain.

Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.

Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma.

P304

1065-1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1369/JHC.2008.951855

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Steven T Dekosky

P577

2008-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23148156

http://www.w3.org/2001/XMLSchema#string

P698

18678882

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2583907

http://www.w3.org/2001/XMLSchema#string